abc-logo
  • Latest Articles
  • Diseases
    • Autoimmune Diseases
      • Arthritis
      • Crohn's Disease
      • Juvenile Arthritis
      • Lupus
      • Rheumatoid Arthritis
      • Type 1 Diabetes
      • Type 2 Diabetes
    • Cancer
      • Destroying the Cancer Threat
      • Myeloma
      • Leukemia
      • Lymphoma
      • Breast Cancer
      • Cervical Cancer
      • Brain Cancer
      • Colon Cancer
      • Kidney Cancer
      • Stomach Cancer
      • Lung Cancer
      • Skin Cancer
    • Heart Diseases
      • Heart Transplant
      • Heart Disease
      • High Cholesterol
      • Obesity
    • Infectious Diseases
      • Coronavirus
      • HIV/AIDS
      • Hepatitis C
      • HPV
    • Mental Health
      • Depression
      • Schizophrenia
      • Bipolar Disorder
    • Neurological Diseases
      • ALS
      • Alzheimer's
      • Epilepsy
      • Migraine
      • Multiple Sclerosis
      • Parkinson's
    • Treatment Approaches
      • Genomics
      • Vaccines
      • Immunologic
      • Treatments
  • About Us
    • Our Commitment
      • Development Pipeline
      • Innovation Fragility
      • Innovation Offsets
      • Accessibility & Affordability
      • R&D Commitment
    • Faces of Innovation
      • Champions / Advocates
      • Patient Profiles
      • Researcher Profiles
    • Member Companies
      • Who We Are
    • Campaigns
      • Breakthrough
      • Together
      • Do Not Go Gentle
      • New World
      • Cells
      • New Era of Medicine
    • Collaboration & Events
      • Events
  • SEARCH
  •  STAY AHEAD
  • Take Action
Hero Image Pattern 6
  1. Home
  2. About Us
  3. Our Commitment
  4. Economic Impact
  5. The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors

The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors

Economic Impact
R&D Commitment
Innovation Offsets
Advocacy / Policy

The Importance of Investment

Today, there are 7,000 new medications being developed by biopharmaceutical companies around the globe. Investors look many factors when deciding to fund this research, including market size, demand, and the local policy environment. Data shows that countries that offer protection of intellectual property (IP) rights, as well as those with inclusive R&D policies, are most likely to benefit from the billions of dollars invested annually into the biopharmaceutical industry. In addition to fueling treatments and cures, a supportive policy environment keeps the United States competitive for investors, both foreign and domestic.

There are 7,000 new medications being developed by biopharmaceutical companies around the globe.

The Impact of Investment

The impact of biopharmaceutical investment is not just measured by improved health care and quality of life for patients. We can also see the direct, measurable impact by studying a nation’s economy and the development of its workforce.

 

For America, this economic impact is massive. The U.S. biopharmaceutical sector employs more than 803,000 workers, ultimately supporting millions of jobs across the country. This impact would not be possible without the investment obtained through our competitive culture of innovation and IP protection.

 

Analyzing investment across countries shows that while the US is highly competitive, we may face challenges in certain regulatory areas. Remaining a leader in the global market for biopharmaceutical investment is key to continued job creation and economic strength.

The U.S. biopharmaceutical sector employs more than 850,000 workers, ultimately supporting millions of jobs across the country.

Read the comparative analysis of 15 countries here.


RELATED TOPICS

Economic Impact
R&D Commitment
Innovation Offsets
Advocacy / Policy

Share:

  • #GoBoldly

Explore the innovative research and technological breakthroughs of America's biopharmaceutical industry, and get to know the people behind the fight to prevent, treat and cure disease.

abc-logo
Privacy Policy Patient Resources Terms of Service PhRMA.org

©2018 Pharmaceutical Research and Manufacturers of America, 950 F Street NW, Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.

  • DISEASES
  • Cancer
  • Heart Diseases
  • Infectious Diseases
  • Autoimmune Diseases
  • Mental Health
  • Neurological Diseases
  • Treatment Approaches

  • Take Action

  • About Us
  • Collaboration & Events
  • Our Commitment
  • Member Companies
  • Campaigns
  • Faces of Innovation
Privacy Policy Patient Resources Terms of Service PhRMA.org

©2018 Pharmaceutical Research and Manufacturers of America, 950 F Street NW, Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.